Latest Agreements Could Improve Chinese Markets For US Devices
This article was originally published in The Gray Sheet
American and Chinese officials at the US-China Joint Commission on Commerce and Trade have negotiated several challenges to address during the next year that could make it easier for domestic medical device manufacturers to enter the Chinese market.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.